Wegovy, Ozempic, and other generic forms of semaglutide are currently not covered under Medicare due to its primary designation as a diabetes treatment
Semaglutide and Tirzepatide on the FDA Drug Shortage List Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are GLP-1 receptor agonists used for treating type 2 diabetes and obesity
Options include compounded semaglutide and compounded tirzepatide , along with non-GLP-1 alternatives like metformin, naltrexone, and bupropion
The colonic crypt protects stem cells from Microbiota-Derived metabolites
A legitimate Orange County clinic should evaluate medical history, current medications, symptoms, appropriate lab considerations, and weight-related goals before recommending treatment